Table 1.
Characteristic | All Patients who were Prescribed PrEP (N = 663) |
---|---|
Age, at first PrEP prescription (n, %) | |
18 to 24 | 88 (13.3) |
25 to 29 | 168 (25.3) |
30 to 39 | 208 (31.4) |
40+ | 199 (30.0) |
Gender (n, %) | |
Male | 636 (95.9) |
Female | 3 (0.5) |
Transgender female or trans‐feminine identifying | 20 (3.0) |
Transgender male or trans‐masculine identifying | 4 (0.6) |
Race and ethnicity (n, %) | |
White (non‐hispanic) | 481 (72.6) |
Black | 43 (6.5) |
Asian or Pacific Islander | 24 (3.6) |
Multiracial/other | 61 (9.2) |
Hispanic or Latinx | 44 (6.6) |
Missing | 10 (1.5) |
Relationship status, at first PrEP prescription (n, %) | |
Singlea | 398 (60.0) |
Committed relationship | 265 (40.0) |
HIV‐infected partner | 100 (15.1) |
HIV‐uninfected partner/Not documented | 165 (24.9) |
Employment status (n, %) | |
Full‐time | 517 (78.0) |
Part‐time | 8 (1.2) |
Unemployed | 21 (3.2) |
Student | 72 (10.9) |
Disabled | 8 (1.2) |
Retired | 1 (0.2) |
Unknown | 36 (5.4) |
Mental health disorder, everb (n, %) | |
Anxiety | 247 (37.3) |
Depression | 240 (36.2) |
Attention deficit disorderc | 106 (16.0) |
Post‐traumatic stress disorder | 33 (5.0) |
Bipolar disorder or schizophrenia | 24 (3.6) |
Substance use disorder, ever (n, %) | |
Non‐alcohol recreational drugb | 72 (10.9) |
Crystal methamphetamine | 52 (7.8) |
Cocaine | 23 (3.5) |
Gamma‐hydroxybutyric acid | 11 (1.7) |
Alcohol | 73 (11.0) |
Marijuana | 28 (4.2) |
Injection drug use, ever (n, %) | 28 (4.2) |
Insurance status, at first PrEP prescriptionb (n, %) | |
Private | 559 (84.3) |
Medicaid | 84 (12.7) |
Medicare | 13 (2.0) |
No insurance | 5 (0.8) |
Other | 27 (4.1) |
Hepatitis B statusd | |
Immune | 430 (64.9) |
Susceptible | 159 (24.0) |
Isolated positive hepatitis B core antibody | 7 (1.1) |
Chronic hepatitis B infectione | 1 (0.2) |
Not documented | 66 (10.0) |
PrEP, preexposure prophylaxis; SD, standard deviation. aIncludes divorced, formal separation, widowed, and any patient without documentation of committed relationship. bCategories not mutually exclusive. cIncludes attention deficit disorder and attention deficit hyperactivity disorder. dPatients with positive hepatitis B surface antibody with or without positive hepatitis B core antibody were categorized as immune to hepatitis B. eThis patient did not experience an acute exacerbation of chronic hepatitis B during the study period.